Company Quratis Inc.

Equities

A348080

KR7348080003

Pharmaceuticals

End-of-day quote Korea S.E. 03:30:00 04/06/2024 am IST 5-day change 1st Jan Change
1,239 KRW -5.35% Intraday chart for Quratis Inc. -9.10% -43.30%

Business Summary

Quratis Inc is a Korea-based company primarily engaged in the manufacture and sale of biopharmaceuticals. The Company is engaged in the manufacture and sale of vaccine, peptide nucleic acid complex. The Company is also engaged in the provision of Cell Penetrating Peptide (CPP) platform services. In addition, the Company is engaged in the development and research of vaccines, such as tuberculosis vaccines for adults and adolescents, and COVID-19 vaccines.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Development
100.0 %
8,409 100.0 % 1,030 100.0 % -87.75%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
8,409 100.0 % 1,030 100.0 % -87.75%

Managers

Managers TitleAgeSince
Chief Executive Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 42,152,010 31,146,099 ( 73.89 %) 0 73.89 %
Stock B 0 213,612 0 0

Shareholders

NameEquities%Valuation
2,763,220 6.555 % 3 M ₩
Linfra Corp.
5.632 %
2,373,887 5.632 % 3 M ₩
Kiwoom-Yollim Healthcare Investment Association No 1
5.590 %
2,356,468 5.590 % 3 M ₩
SJ Investment Partners Co., Ltd.
4.598 %
1,938,082 4.598 % 2 M ₩
Kclavis Investment Co. Ltd.
3.660 %
1,542,857 3.660 % 2 M ₩
Korea Asset Investment Securities Co. Ltd. /Venture Capital/
2.834 %
1,194,516 2.834 % 1 M ₩
Asset One
2.425 %
1,022,239 2.425 % 1 M ₩
Eun-Ju Lee
1.898 %
800,000 1.898 % 885 608 ₩
Yonsei Medical Clinic
1.139 %
480,000 1.139 % 531 365 ₩
416,666 0.9885 % 461 253 ₩

Company contact information

Quratis, Inc.

9th Floor, Daeryeong Seocho Tower 327 Gangnam-daero

06627, Seoul

+

http://www.quratis.com
address Quratis Inc.(A348080)